Difficulty: Medium
Average Score: 64%
Practice
Which of the following chromosomal abnormalities of childhood ALL carries the highest risk of relapse despite intensive chemotherapy?
Correct answer
A
Rationale
In pediatric oncology, understanding chromosomal abnormalities associated with childhood acute lymphoblastic leukemia (ALL) is crucial. The correct answer is A) t(9;22), also known as the Philadelphia chromosome. This abnormality involves a translocation between chromosomes 9 and 22, resulting in the BCR-ABL fusion gene. This genetic alteration leads to a more aggressive disease course and is associated with a higher risk of relapse despite intensive chemotherapy.
Option B) t(4;11) refers to the MLL gene rearrangement, which is associated with an intermediate risk of relapse in childhood ALL. While it is a poor prognostic indicator, it does not carry as high a risk of relapse as the Philadelphia chromosome.
Option C) hypodiploidy, characterized by fewer than 44 chromosomes, is associated with a very high-risk subtype of childhood ALL. Children with hypodiploidy often have a poor response to therapy but do not specifically carry the highest risk of relapse compared to the Philadelphia chromosome.
Option D) t(1;19) refers to the E2A-PBX1 fusion gene. This genetic abnormality is associated with a favorable prognosis in childhood ALL and is not linked to the highest risk of relapse compared to the Philadelphia chromosome.
Educationally, understanding the significance of different chromosomal abnormalities in childhood ALL is essential for nurses caring for pediatric oncology patients. Recognizing these genetic markers can help healthcare providers tailor treatment plans, monitor for potential complications, and educate patients and families about the disease course and prognosis.
Option B) t(4;11) refers to the MLL gene rearrangement, which is associated with an intermediate risk of relapse in childhood ALL. While it is a poor prognostic indicator, it does not carry as high a risk of relapse as the Philadelphia chromosome.
Option C) hypodiploidy, characterized by fewer than 44 chromosomes, is associated with a very high-risk subtype of childhood ALL. Children with hypodiploidy often have a poor response to therapy but do not specifically carry the highest risk of relapse compared to the Philadelphia chromosome.
Option D) t(1;19) refers to the E2A-PBX1 fusion gene. This genetic abnormality is associated with a favorable prognosis in childhood ALL and is not linked to the highest risk of relapse compared to the Philadelphia chromosome.
Educationally, understanding the significance of different chromosomal abnormalities in childhood ALL is essential for nurses caring for pediatric oncology patients. Recognizing these genetic markers can help healthcare providers tailor treatment plans, monitor for potential complications, and educate patients and families about the disease course and prognosis.